G protein-coupled receptor 119 agonist DS-8500a effects on pancreatic β-cells in Japanese type 2 diabetes mellitus patients-Reference-Cited by-同舟云学术

G protein-coupled receptor 119 agonist DS-8500a effects on pancreatic β-cells in Japanese type 2 diabetes mellitus patients

Published:2018-05-04 Issue:1 Volume:10 Page:84-93
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Watada Hirotaka¹^ORCID,Shiramoto Masanari²^ORCID,Irie Shin²,Terauchi Yasuo³,Yamada Yuichiro⁴,Shiosakai Kazuhito⁵,Myobatake Yusuke⁶,Taguchi Takashi⁶^ORCID

Affiliation:

1. Department of Metabolism and Endocrinology; Juntendo University Graduate School of Medicine; Tokyo Japan

2. SOUSEIKAI Hakata Clinic; Hakata Fukuoka Japan

3. Department of Endocrinology and Metabolism; Yokohama City University Graduate School of Medicine; Yokohama Kanagawa Japan

4. Department of Endocrinology, Diabetes and Geriatric Medicine; Akita University School of Medicine; Akita Japan

5. Biostatistics & Data Management; Daiichi Sankyo Co., Ltd; Tokyo Japan

6. Clinical Development Department, Daiichi Sankyo Co., Ltd; Tokyo Japan

Funder

Daiichi Sankyo Co., Ltd.

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12849/fullpdf

Reference30 articles.

1. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants;NCD Risk Factor Collaboration (NCD-RisC);Lancet,2016

2. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis;Kodama;Diabetes Care,2013

3. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests;Brunzell;J Clin Endocrinol Metab,1976

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates;Expert Opinion on Investigational Drugs;2024-02-23

2. GPCRs involved in metabolic diseases: pharmacotherapeutic development updates;Acta Pharmacologica Sinica;2024-02-07

3. Next-Generation Therapies for Type 2 Diabetes Mellitus;Smart Nanomaterials Technology;2024

4. Structural Insight on GPR119 Agonist as Potential Therapy for Type II Diabetes: A Comprehensive Review;Mini-Reviews in Medicinal Chemistry;2023-11

5. New Horizons: Emerging Antidiabetic Medications;The Journal of Clinical Endocrinology & Metabolism;2022-09-15